These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 23165779)
1. Simultaneous in vivo pH and temperature mapping using a PARACEST-MRI contrast agent. McVicar N; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R Magn Reson Med; 2013 Oct; 70(4):1016-25. PubMed ID: 23165779 [TBL] [Abstract][Full Text] [Related]
2. A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe). Li AX; Wojciechowski F; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R Magn Reson Med; 2008 Feb; 59(2):374-81. PubMed ID: 18228602 [TBL] [Abstract][Full Text] [Related]
3. A DOTAM-based paraCEST agent favoring TSAP geometry for enhanced amide proton chemical shift dispersion and temperature sensitivity. Stevens TK; Milne M; Elmehriki AA; Suchý M; Bartha R; Hudson RH Contrast Media Mol Imaging; 2013; 8(3):289-92. PubMed ID: 23606433 [TBL] [Abstract][Full Text] [Related]
4. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T. Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213 [TBL] [Abstract][Full Text] [Related]
5. MRI CEST at 1T with large µeff Ln(3+) complexes T m(3+)-HPDO3A: An efficient MRI pH reporter. Rancan G; Delli Castelli D; Aime S Magn Reson Med; 2016 Jan; 75(1):329-36. PubMed ID: 25651986 [TBL] [Abstract][Full Text] [Related]
6. DOTAM-type ligands possessing arginine pendant groups for use in PARACEST MRI. Suchý M; Li AX; Milne M; Bartha R; Hudson RH Contrast Media Mol Imaging; 2012; 7(5):441-9. PubMed ID: 22821878 [TBL] [Abstract][Full Text] [Related]
7. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Aime S; Barge A; Delli Castelli D; Fedeli F; Mortillaro A; Nielsen FU; Terreno E Magn Reson Med; 2002 Apr; 47(4):639-48. PubMed ID: 11948724 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of MRI contrast agents derived from DOTAM-Gly-L-Phe-OH incorporating a disulfide bridge: conjugation to a cell penetrating peptide and preparation of a dimeric agent. Suchý M; Li AX; Bartha R; Hudson RH Bioorg Med Chem Lett; 2010 Sep; 20(18):5521-6. PubMed ID: 20705462 [TBL] [Abstract][Full Text] [Related]
9. In vivo maps of extracellular pH in murine melanoma by CEST-MRI. Delli Castelli D; Ferrauto G; Cutrin JC; Terreno E; Aime S Magn Reson Med; 2014 Jan; 71(1):326-32. PubMed ID: 23529973 [TBL] [Abstract][Full Text] [Related]
11. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857 [TBL] [Abstract][Full Text] [Related]
12. Analogs of Eu3+ DOTAM-Gly-Phe-OH and Tm3+ DOTAM-Gly-Lys-OH: synthesis and magnetic properties of potential PARACEST MRI contrast agents. Suchý M; Li AX; Bartha R; Hudson RH Bioorg Med Chem; 2008 Jun; 16(11):6156-66. PubMed ID: 18457955 [TBL] [Abstract][Full Text] [Related]
13. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems. Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147 [TBL] [Abstract][Full Text] [Related]
14. pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent. Wu Y; Zhang S; Soesbe TC; Yu J; Vinogradov E; Lenkinski RE; Sherry AD Magn Reson Med; 2016 Jun; 75(6):2432-41. PubMed ID: 26173637 [TBL] [Abstract][Full Text] [Related]
16. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination. Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818 [TBL] [Abstract][Full Text] [Related]
17. Measuring in vivo tumor pHe with CEST-FISP MRI. Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287 [TBL] [Abstract][Full Text] [Related]
18. A robust and convergent synthesis of dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents. Wojciechowski F; Suchy M; Li AX; Azab HA; Bartha R; Hudson RH Bioconjug Chem; 2007; 18(5):1625-36. PubMed ID: 17711349 [TBL] [Abstract][Full Text] [Related]
19. Yb(III)-HPDO3A: a dual pH- and temperature-responsive CEST agent. Delli Castelli D; Terreno E; Aime S Angew Chem Int Ed Engl; 2011 Feb; 50(8):1798-800. PubMed ID: 21328642 [No Abstract] [Full Text] [Related]
20. High-resolution pH imaging using ratiometric chemical exchange saturation transfer combined with biosensor imaging of redundant deviation in shifts featuring paramagnetic DOTA-tetraglycinate agents. Mihailovic JM; Huang Y; Walsh JJ; Khan MH; Mishra SK; Samuels S; Hyder F; Coman D NMR Biomed; 2022 May; 35(5):e4658. PubMed ID: 34837412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]